Calithera Biosciences Inc (CALA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO, CA 94080

Calithera Biosciences, Inc. provides pharmaceutical products. The Company is focused on discovering and developing novel small molecule drugs directed against tumor metaboli® and tumor immunology targets for the treatment of cancer.

Data based on most recent fiscal year report
Market Cap207.558 Million Shares Outstanding35.48 Million Avg Volume1.109 Million
1-Yr BETA vs S&P TR1.394 Current Ratio4.3 Quick Ratio4.3
View SEC Filings from CALA instead.
Q2 2019 All Institutions Hedge Funds 1
To trade CALA now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 93 21 (2.17%)
Aggregate 13F shares on 06/30/2019: 34.337 Million 10.765 Million
Aggregate 13F shares on 03/31/2019: 22.252 Million 4.903 Million
Percent change: 54.31% 119.55%
Funds creating new positions: 27 10
Funds Adding to an existing position: 36 8
Funds closing out their position: 4 1
Funds reducing their position: 16 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CALA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
342,843 2019-10-04 1

DRACHMAN JONATHAN G SEE REMARKS

  • Officer
  • Director
591,856 2019-09-09 1

WOLFF HENRY WARD

  • Director
0 2019-06-28 1

GEORGE JEAN

  • Director
3,750 2019-06-26 1

MOLINEAUX SUSAN PRESIDENT AND CEO

  • Officer
  • Director
462,188 2019-06-25 4

MOLINEAUX CHRISTOPHER SR. VP, DEVELOPMENT

  • Officer
462,188 2019-06-25 4

SJOGREN ERIC SR. VP, DRUG DISCOVERY

  • Officer
72,057 2019-06-24 2

WONG STEPHANIE SR. VP, FINANCE & SECRETARY

  • Officer
42,301 2019-06-19 2

ORFORD KEITH CHIEF MEDICAL OFFICER

  • Officer
12,083 2019-06-17 6

PARLATI FRANCESCO VP, RESEARCH

  • Officer
42,201 2019-06-17 2

AGARWAL SUNIL

  • Director
0 2019-06-13 1

WADDILL WILLIAM D.

  • Director
0 2019-06-07 0

PAKIANATHAN DEEPIKA

  • Director
0 2019-06-06 1

JONES SUZY

  • Director
0 2019-05-30 1

WISE BLAKE

  • Director
0 2019-05-30 1

HECHT CURTIS SVP, CHIEF BUSINESS OFFICER

  • Officer
0 2019-01-10 1

RAY SUMITA SEE REMARKS

  • Officer
0 2019-01-10 1

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2017-12-31 0

MORGENTHALER VENTURE PARTNERS IX LP

  • 10% Owner
No longer subject to file 2017-06-01 0

BENNETT MARK K SR. VP, RESEARCH

  • Officer
0 2016-11-29 0

DELPHI MANAGEMENT PARTNERS VIII, L.L.C.

BOCHNOWSKI JAMES J

DELPHI BIOINVESTMENTS VIII LP

DELPHI VENTURES VIII LP

DOUGLASS DAVID L

PAKIANATHAN DEEPIKA

ROEDER DOUGLAS A

  • Director
  • 10% Owner
11,346,946 2016-03-23 0

ADVANCED TECHNOLOGY VENTURES VIII LP

ATV ASSOCIATES VIII, L.L.C.

  • 10% Owner
0 2015-06-24 0

CHRISTOFFERSEN RALPH E

  • Director
  • 10% Owner
2,161,915 2014-10-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments